A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)

PHASE2CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

February 1, 2018

Study Completion Date

February 1, 2018

Conditions
Cystic Fibrosis
Interventions
DRUG

Gallium nitrate

Study subjects will receive an infusion of either placebo or gallium nitrate.

DRUG

Normal Saline

Study subjects will receive an infusion of either placebo (normal saline) or gallium nitrate.

Trial Locations (23)

15224

Pittsburgh Adult, Children's Hospital of Pittsburgh UPMC, Pittsburgh

21205

Baltimore Hopkins Adult / John Hopkins Hospital, Baltimore

29425

SC CC and Adult Charleston / MUSC, Charleston

30322

Atlanta Emory Adult / Emory University Hospital, Atlanta

32610

Shands Hospital, Gainesville

33136

Jackson Memorial Hospital; University of Miami Hospital; University of Miami Hospital and Clinics, Miami

35233

AL Adult Birmingham / The Children's Hospital Atlanta, Birmingham

43205

Columbus CC and Peds / Nationwide Children's Hospital, Columbus

43606

Toledo, OH CC and Peds / The Toledo Hospital; Toledo Children's Hospital, Toledo

44106

Cleveland CC and Peds, Hospital of Cleveland, Cleveland

52242

Iowa City University of Iowa Adult / University of Iowa Hospitals & Clinics, Iowa City

55455

Minneapolis CC and Adult / University of Minnesota Medical Center, Fairview, Minneapolis

60611

Chicago Northwestern Adult / Northwestern Memorial Hospital, Chicago

73104

Oklahoma City Adult / Presbyterian Hospital at OU Medical Center, Oklahoma City

80206

Denver Adult / National Jewish Health, Denver

84132

Salt Lake City Adult, Intermountain Cystic Fibrosis Center, Salt Lake City

92037

UC San Diego Medical Center, La Jolla

98195

Seattle UW Adult / University of Washington Medical Center, Seattle

40506-9983

Lexington, KY Adult / University of Kentucky Chandler Medical Center, Lexington

04102

Portland, ME Adult, Portland

02115

Boston CHB Adult / Boston Children's Hospital (BCH), Boston

68198-5300

Omaha Adult / The Nebraska Medical Center, Omaha

03756

Lebanon, NH Dartmouth-Hitchcock CC and Adult / Dartmouth Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

University of Washington

OTHER

NCT02354859 - A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study) | Biotech Hunter | Biotech Hunter